Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)

R.J. Lurvink, K.P. Rovers, E.C.E. Wassenaar, C. Bakkers, J.W.A. Burger, G.J.M. Creemers, M. Los, F. Mols, M.J. Wiezer, S.W. Nienhuijs, D. Boerma, I.H.J.T. de Hingh*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages13
JournalSurgical endoscopy and other interventional techniques
DOIs
Publication statusE-pub ahead of print - 10 Nov 2021

Keywords

  • Colorectal neoplasms
  • Peritoneal neoplasms
  • Antineoplastic agents
  • Oxaliplatin
  • Patient-reported outcome measures
  • Quality of life
  • QUALITY-OF-LIFE
  • EUROPEAN-ORGANIZATION
  • CANCER PATIENTS
  • CARCINOMATOSIS
  • RATIONALE
  • QUESTIONNAIRE
  • SURVIVAL
  • WOMEN

Cite this